-- 据路透社周三援引欧盟外交官的话报道,欧盟向成员国发出严厉警告,称中东冲突若持续,可能引发长期供应冲击,迫使各国削减燃料消费。 自2月28日冲突爆发以来,通常承载着全球20%石油和液化天然气运输的霍尔木兹海峡一直处于关闭状态,这给全球能源市场带来了巨大冲击。 尽管欧洲尚未面临供应短缺,但日益加剧的能源危机正对欧洲大陆经济造成冲击。创纪录的油气价格令消费者不堪重负,航空业也面临着新的威胁。 报道称,面对迫在眉睫的能源危机,欧盟委员会正在考虑两种主要方案。 欧盟委员会表示,如果美伊停火协议得以维持,华盛顿解除对霍尔木兹海峡的封锁,油气运输有望在数月内恢复正常,从而有助于降低油价。 欧盟委员会尚未回复的置评请求。 柴油和航空煤油市场需要更长时间才能恢复平衡,预计价格将在夏季末期有所回落。然而,受卡塔尔关键基础设施受损的影响,全球液化天然气(LNG)市场可能在2030年之前持续紧张。 然而,如果冲突持续,能源市场将面临长期供应冲击和价格飙升的风险,并对整个工业供应链产生连锁反应。报告指出,石油供应的持续中断将日益引发“需求萎缩”,从而抑制燃料消费。 欧盟表示,在这种情况下,欧盟可能难以在冬季到来之前补充天然气库存,同时可能出现局部地区的航空煤油短缺。 欧盟委员会正在制定一揽子措施以缓解能源冲击,其中包括降低电力税和加快清洁技术推广的提案。其目标是减少欧盟对化石燃料的依赖,并使其免受未来油气供应中断的影响。 (市场动态新闻来源于与全球市场专业人士的对话。这些信息据信来自可靠来源,但可能包含传闻和推测。准确性无法保证。)
Related Articles
Canada's Retail Sales Momentum May Fade Later in The Year, Says National Bank
Statistics Canada's advance estimate points to a 0.6% month-over-month nominal increase in March retail sales, said National Bank of Canada after Friday's data.Given the surge in gasoline prices that occurred in the month, this figure heavily reflects higher prices at the pump. As a result, in real terms, retail sales could register a contraction in the final month of Q1, noted the bank.Nonetheless, for the quarter, information received to date indicates that real retail sales could grow at a 4.7% annualized pace, following a 2.0% decline in the previous quarter -- marking the strongest quarterly performance since Q4 2024, stated National Bank.This is all the more impressive as it is occurring against a backdrop of demographic contraction, pointed out the bank.Indeed, the most recent figures from StatsCan indicate that the country's population declined for a second consecutive quarter -- an unprecedented development.As a result, real retail spending per capita is tracking a 5.2% increase in Q1, a rebound from the sluggish prints seen in 2025. Still, National Bank thinks that this momentum could fade fast as the year progresses.As a result of the conflict in the Middle East, households will face an erosion in purchasing power in the coming months. This, combined with a mortgage interest-payment shock and a still fragile labor market, could weigh on discretionary spending going forward, according to the bank.
Cinemark Likely to Benefit From Release Slate, Wedbush Says
Cinemark (CNK) is set to benefit from a more consistent release slate over the next several quarters and further market share gains, Wedbush said in a Monday note."The summer slate, especially in Q3, is shaping up very nicely," the report said.The note said theater investments, including laser projectors, premium seats and screens, IMAX expansion, and strategic pricing could drive market share gains. It also pointed to other benefits such as new builds and returning cash to shareholders.For its Q1 results due May 1, Wedbush expects Cinemark to post Q1 revenue of $638 million, against consensus of $629 million, and a loss of $0.03 per share, against consensus of $0.16 loss.Wedbush kept its outperform rating and a $37 price target.Price: $29.40, Change: $+0.92, Percent Change: +3.23%
Swiss Market Index Closes Little Changed; Santhera Shares Jump
The blue-chip Swiss Market Index was down 0.03% on Monday's close, as investors gear up for a busy week of corporate updates, economic data prints and key monetary policy decisions.Santhera Pharmaceuticals (SANN.SW) secured a positive recommendation from the European Medicines Agency's Committee for Medicinal Products for Human Use to expand the approval of its Duchenne muscular dystrophy drug Agamree to include the treatment of children who are at least two years old. The drug is currently approved for use on patients aged four and above. The Swiss specialty pharmaceutical company's shares gained 8.38% at closing.Meanwhile, RBC Capital Markets reiterated its outperform rating on Lonza Group (LONN.SW), with a price target of 670 francs, amid expectations that the Swiss pharmaceutical manufacturer's upcoming first-quarter update would be "uneventful." At the end of the trading day, the stock was up 1.83%."We do not see the Q1 qualitative update on 8 May to be a major catalyst for the stock now that Vacaville-specific commentary will no longer be provided, and any further weakness in Specialized Modalities should not be a surprise. We have also taken the opportunity to refresh and add to our commercial product (Enflonsia) and pipeline trackers. There has been some clinical progress, but consensus forecasts have been pushed out a little (aggregate peak sales estimates are unchanged)," the research firm said, noting that it views Lonza as an "attractive and undervalued compounding investment story."The local economic news calendar was empty for the day, while the release of the Swiss KOF Economic Barometer and the UBS & CFA Society Switzerland's economic sentiment index for April, as well as the country's March retail sales figures are on the agenda over the coming days. Market watchers are also awaiting the rate decisions of the US Federal Reserve, the European Central Bank, and the Bank of England.